Chitosan/nanoparticle composites and their research findings
Chitosan/nanoparticle composite | Drug/molecule loaded | Purpose | In vitro cell response | In vivo response | Ref. |
---|---|---|---|---|---|
Chitosan/glycosaminoglycan/AgNP electrospun scaffold | - | Antibacterial scaffolds for better wound healing | Good cell viability; antibacterial property against both E. coli and Staphylococcus aureus | - | [83] |
Chitosan-L-glutamic acid (CG) derivative/silver nanoparticles | Hyaluronic acid | Antibacterial wound dressings | Non-toxic to L929 cells size of the inhibition zone increased in a concentration-dependent manner average diameters of the zones for composites against E. coli and S. aureus increased from 20.5–33.0 mm and from 15.5–19.5 mm, respectively | Evidence of healing on day 3, with calluses and slight inflammation | [84] |
Silver nanoparticle-impregnated chitosan-PEG hydrogel | - | Wound healing in diabetes-induced rabbits | The zone of inhibition against E. coli, Pseudomonas aeruginosa, Bacillus subtilis and S. aureus was 20.2 ± 1.0, 21.8 ± 1.5, 15.5 ± 0.8 and 21.5 ± 0.5 mm, respectively | AgNPs incorporated chitosan-PEG hydrogel group was even faster than the healing of wounds with a positive control (32.9 ± 2.1%) | [85] |
Chitosan-loaded silver nanoparticles | Iturin | Antibacterial and wound care applications | Inhibition zone for both E. coli ATCC25922 and S. aureus ATCC29213 | The wound area gradually decreased from the 7th day after the application of sponge dressing | [86] |
PEO/chitosan nanofibers/ZnO | Ciprofloxacin | Burn infection management | Better antibacterial activity of Cip loaded nano webs at 1 μg/mL concentration; ciprofloxacin loaded nano webs 82.5% cell viability HDF cells | - | [87] |
Chitosan/polyethylene glycol/copper film | Naproxen | Anti-infection wound dressing | Cu2+ ions release inhibited biofilm formation; films with 0.1 mM Cu demonstrated better adhesion and proliferation of human skin keratinocytes A341 cell lines | - | [88] |
Copper nanoparticle/chitosan/gelatin composite scaffold | - | Skin tissue engineering application | Scaffolds with copper concentration of 0.01% showed a higher proliferation rate; no oxidative stress upon DCFDA staining. After 7 days, uniform layer of fibroblast cells over the scaffold’s surface | - | [89] |
Chitosan-based copper nanocomposite (CCNC) | - | Wound healing | - | Decreased TNF-α production on 3rd, 7th and 11th day; can decrease the inflammatory reaction; enhanced fibroblast proliferation and collagen deposition; promoted intact re-epithelialization in rats | [90] |
Chitosan/AuNPs composite | - | Antimicrobial wound dressing | Composite was non-toxic to normal human skin cell line BJ-1; maximum inhibition against P. aeruginosa, with inhibition zone diameter of 26 ± 1.8 mm; better antifungal activity against unicellular fungi than multicellular fungi | - | [91] |
Polyacrylic acid/carboxymethyl chitosan/ultrasmall gold nanoparticles (PAA-CMCS-UsAuNPs) | - | Antibacterial hydrogel | Disorder of the surface charge of bacteria and the damage bacterial membrane; ROS production increased in both S. aureus and E. coli to a level of 200% and 300% after hydrogel exposure | On day 4, hydrogel produced significant regeneration of the epidermis in a full-thickness skin wound model. On day 8, a reduction in inflammatory cells | [92] |
Castor oil (CO)/chitosan/ZnO NP (CS/ZnO) | - | Antibacterial wound dressings | Biocidal activity increased with increased CS/ZnO content; stronger bactericidal effect on Gram-positive cells S. aureus and Micrococcus luteus; after 24 h, CS/ZnO loadings ≤ 5.0 wt%, with 90–97% cell; slight increase in cell viability after 72 h of incubation | Wound closure after 14 days in full-thickness wounds on the back of Sprague-Dawley rats | [93] |
Chitosan/CuO-NP | - | Anti-coagulant in wound healing | Cryptococcus neoformans could not grow at 10,000 mg/L concentration of chitosan-NP’s; at 10,000 mg/L, chitosan/CuO nanocomposites inhibited the growth of C. neoformans, B. subtilis, and E. coli; B. subtilis was more sensitive than S. aureus and E. coli; good anticoagulant property | - | [94] |
Chitosan/polyvinyl alcohol/TiO2 composite membranes | - | Wound regeneration | Better hemocompatibility demonstrated by erythrocyte lysis of 3.52%. In vitro wound closure rate of 92.3% at 48 h in fibroblast HIH3T3 cells | - | [95] |
Chitosan/TiO2 composite membrane | - | Wound dressing and skin regeneration | Enhanced L929 proliferation and survival, reduced oxidative stress and apoptosis | - | [96] |
ASD: Writing—original draft, Writing—review & editing. NM and RM: Conceptualization, Writing—review & editing. All authors read and approved the submitted version
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
ASD acknowledges Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram, Kerala, India, for providing financial support through the fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
© The Author(s) 2025.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.